nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—ankylosing spondylitis	0.0119	0.511	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00104	0.0446	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00104	0.0446	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00102	0.0439	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00102	0.0439	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—ankylosing spondylitis	0.001	0.0429	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.001	0.0429	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—ankylosing spondylitis	0.00095	0.0407	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—ankylosing spondylitis	0.00095	0.0407	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—ankylosing spondylitis	0.000927	0.0397	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000927	0.0397	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—ankylosing spondylitis	0.000778	0.0334	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.00076	0.0326	CbGdCrCtD
Epirubicin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000556	0.000569	CcSEcCtD
Epirubicin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000555	0.000569	CcSEcCtD
Epirubicin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000555	0.000569	CcSEcCtD
Epirubicin—Epistaxis—Methotrexate—ankylosing spondylitis	0.000555	0.000568	CcSEcCtD
Epirubicin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000555	0.000568	CcSEcCtD
Epirubicin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000555	0.000568	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—ankylosing spondylitis	0.000554	0.000567	CcSEcCtD
Epirubicin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000554	0.000567	CcSEcCtD
Epirubicin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000551	0.000564	CcSEcCtD
Epirubicin—Erythema—Prednisone—ankylosing spondylitis	0.00055	0.000563	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—ankylosing spondylitis	0.00055	0.000563	CcSEcCtD
Epirubicin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00055	0.000563	CcSEcCtD
Epirubicin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000549	0.000562	CcSEcCtD
Epirubicin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000548	0.000561	CcSEcCtD
Epirubicin—Convulsion—Betamethasone—ankylosing spondylitis	0.000548	0.000561	CcSEcCtD
Epirubicin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000548	0.000561	CcSEcCtD
Epirubicin—Hypertension—Betamethasone—ankylosing spondylitis	0.000546	0.000559	CcSEcCtD
Epirubicin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000546	0.000559	CcSEcCtD
Epirubicin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000538	0.000551	CcSEcCtD
Epirubicin—Myalgia—Betamethasone—ankylosing spondylitis	0.000538	0.000551	CcSEcCtD
Epirubicin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000536	0.000549	CcSEcCtD
Epirubicin—Anxiety—Betamethasone—ankylosing spondylitis	0.000536	0.000549	CcSEcCtD
Epirubicin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000532	0.000544	CcSEcCtD
Epirubicin—Discomfort—Betamethasone—ankylosing spondylitis	0.000532	0.000544	CcSEcCtD
Epirubicin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000531	0.000544	CcSEcCtD
Epirubicin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00053	0.000543	CcSEcCtD
Epirubicin—Pain—Prednisolone—ankylosing spondylitis	0.000529	0.000541	CcSEcCtD
Epirubicin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000528	0.000541	CcSEcCtD
Epirubicin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000528	0.000541	CcSEcCtD
Epirubicin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000524	0.000537	CcSEcCtD
Epirubicin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000522	0.000534	CcSEcCtD
Epirubicin—Vision blurred—Prednisone—ankylosing spondylitis	0.000519	0.000531	CcSEcCtD
Epirubicin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000518	0.00053	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000518	0.00053	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000517	0.000529	CcSEcCtD
Epirubicin—Oedema—Betamethasone—ankylosing spondylitis	0.000516	0.000528	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000516	0.000528	CcSEcCtD
Epirubicin—Oedema—Dexamethasone—ankylosing spondylitis	0.000516	0.000528	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000516	0.000528	CcSEcCtD
Epirubicin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000514	0.000526	CcSEcCtD
Epirubicin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000513	0.000525	CcSEcCtD
Epirubicin—Infection—Betamethasone—ankylosing spondylitis	0.000512	0.000525	CcSEcCtD
Epirubicin—Infection—Dexamethasone—ankylosing spondylitis	0.000512	0.000525	CcSEcCtD
Epirubicin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000511	0.000523	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00051	0.000523	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000509	0.000522	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000509	0.000521	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—ankylosing spondylitis	0.000509	0.000521	CcSEcCtD
Epirubicin—Anaemia—Prednisone—ankylosing spondylitis	0.000509	0.000521	CcSEcCtD
Epirubicin—Shock—Dexamethasone—ankylosing spondylitis	0.000507	0.00052	CcSEcCtD
Epirubicin—Shock—Betamethasone—ankylosing spondylitis	0.000507	0.00052	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000507	0.000519	CcSEcCtD
Epirubicin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000506	0.000518	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000506	0.000518	CcSEcCtD
Epirubicin—Agitation—Prednisone—ankylosing spondylitis	0.000506	0.000518	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000505	0.000517	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000505	0.000517	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000503	0.000515	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000503	0.000515	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.0005	0.000512	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.0005	0.000511	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000499	0.000511	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000499	0.000511	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000499	0.000511	CcSEcCtD
Epirubicin—Malaise—Prednisone—ankylosing spondylitis	0.000496	0.000508	CcSEcCtD
Epirubicin—Vertigo—Prednisone—ankylosing spondylitis	0.000494	0.000506	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000494	0.000506	CcSEcCtD
Epirubicin—Syncope—Prednisone—ankylosing spondylitis	0.000494	0.000505	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000493	0.000504	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—ankylosing spondylitis	0.000492	0.000503	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000492	0.000503	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—ankylosing spondylitis	0.000491	0.000503	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00049	0.000502	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00049	0.000502	CcSEcCtD
Epirubicin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000489	0.000501	CcSEcCtD
Epirubicin—Pain—Triamcinolone—ankylosing spondylitis	0.000486	0.000498	CcSEcCtD
Epirubicin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000484	0.000495	CcSEcCtD
Epirubicin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000482	0.000493	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—ankylosing spondylitis	0.000482	0.000493	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000479	0.000491	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000477	0.000489	CcSEcCtD
Epirubicin—Convulsion—Prednisone—ankylosing spondylitis	0.000477	0.000488	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000476	0.000488	CcSEcCtD
Epirubicin—Hypertension—Prednisone—ankylosing spondylitis	0.000475	0.000486	CcSEcCtD
Epirubicin—Chills—Methotrexate—ankylosing spondylitis	0.000474	0.000485	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00047	0.000481	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00047	0.000481	CcSEcCtD
Epirubicin—Myalgia—Prednisone—ankylosing spondylitis	0.000469	0.00048	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—ankylosing spondylitis	0.000469	0.00048	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000468	0.00048	CcSEcCtD
Epirubicin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000467	0.000479	CcSEcCtD
Epirubicin—Anxiety—Prednisone—ankylosing spondylitis	0.000467	0.000478	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—ankylosing spondylitis	0.000467	0.000478	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—ankylosing spondylitis	0.000466	0.000478	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000466	0.000478	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000465	0.000476	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000464	0.000475	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000463	0.000474	CcSEcCtD
Epirubicin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000463	0.000474	CcSEcCtD
Epirubicin—Discomfort—Prednisone—ankylosing spondylitis	0.000463	0.000474	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000463	0.000474	CcSEcCtD
Epirubicin—Erythema—Methotrexate—ankylosing spondylitis	0.00046	0.000471	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00046	0.000471	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000455	0.000466	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000454	0.000465	CcSEcCtD
Epirubicin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000454	0.000465	CcSEcCtD
Epirubicin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000452	0.000462	CcSEcCtD
Epirubicin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000451	0.000461	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00045	0.000461	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000449	0.00046	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000449	0.00046	CcSEcCtD
Epirubicin—Oedema—Prednisone—ankylosing spondylitis	0.000449	0.00046	CcSEcCtD
Epirubicin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000448	0.000459	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000448	0.000459	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000448	0.000459	CcSEcCtD
Epirubicin—Infection—Prednisone—ankylosing spondylitis	0.000446	0.000457	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000445	0.000456	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000445	0.000456	CcSEcCtD
Epirubicin—Back pain—Methotrexate—ankylosing spondylitis	0.000445	0.000456	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—ankylosing spondylitis	0.000445	0.000455	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000445	0.000455	CcSEcCtD
Epirubicin—Shock—Prednisone—ankylosing spondylitis	0.000442	0.000452	CcSEcCtD
Epirubicin—Pain—Dexamethasone—ankylosing spondylitis	0.000441	0.000452	CcSEcCtD
Epirubicin—Pain—Betamethasone—ankylosing spondylitis	0.000441	0.000452	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00044	0.000451	CcSEcCtD
Epirubicin—Tachycardia—Prednisone—ankylosing spondylitis	0.000438	0.000449	CcSEcCtD
Epirubicin—Skin disorder—Prednisone—ankylosing spondylitis	0.000436	0.000447	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000434	0.000445	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000433	0.000444	CcSEcCtD
Epirubicin—Anorexia—Prednisone—ankylosing spondylitis	0.000428	0.000438	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000427	0.000437	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—ankylosing spondylitis	0.000425	0.000435	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000425	0.000435	CcSEcCtD
Epirubicin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000425	0.000435	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000422	0.000432	CcSEcCtD
Epirubicin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000422	0.000432	CcSEcCtD
Epirubicin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000419	0.000429	CcSEcCtD
Epirubicin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000418	0.000428	CcSEcCtD
Epirubicin—Malaise—Methotrexate—ankylosing spondylitis	0.000415	0.000425	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—ankylosing spondylitis	0.000413	0.000423	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000412	0.000422	CcSEcCtD
Epirubicin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00041	0.00042	CcSEcCtD
Epirubicin—Urticaria—Betamethasone—ankylosing spondylitis	0.00041	0.00042	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000409	0.000419	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—ankylosing spondylitis	0.000409	0.000419	CcSEcCtD
Epirubicin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000408	0.000418	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000408	0.000417	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000408	0.000417	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000408	0.000417	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000408	0.000417	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000407	0.000417	CcSEcCtD
Epirubicin—Insomnia—Prednisone—ankylosing spondylitis	0.000406	0.000416	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000403	0.000413	CcSEcCtD
Epirubicin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000402	0.000412	CcSEcCtD
Epirubicin—Cough—Methotrexate—ankylosing spondylitis	0.000401	0.000411	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000401	0.000411	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—ankylosing spondylitis	0.000399	0.000408	CcSEcCtD
Epirubicin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000395	0.000405	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—ankylosing spondylitis	0.000392	0.000401	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—ankylosing spondylitis	0.000392	0.000401	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000392	0.000401	CcSEcCtD
Epirubicin—Decreased appetite—Prednisone—ankylosing spondylitis	0.00039	0.0004	CcSEcCtD
Epirubicin—Rash—Prednisolone—ankylosing spondylitis	0.00039	0.000399	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000389	0.000399	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000389	0.000398	CcSEcCtD
Epirubicin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000388	0.000397	CcSEcCtD
Epirubicin—Fatigue—Prednisone—ankylosing spondylitis	0.000387	0.000396	CcSEcCtD
Epirubicin—Headache—Prednisolone—ankylosing spondylitis	0.000387	0.000396	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—ankylosing spondylitis	0.000387	0.000396	CcSEcCtD
Epirubicin—Constipation—Prednisone—ankylosing spondylitis	0.000384	0.000393	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—ankylosing spondylitis	0.000378	0.000388	CcSEcCtD
Epirubicin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000376	0.000385	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000375	0.000384	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000375	0.000384	CcSEcCtD
Epirubicin—Infection—Methotrexate—ankylosing spondylitis	0.000373	0.000382	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00037	0.000379	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00037	0.000379	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—ankylosing spondylitis	0.00037	0.000379	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000368	0.000377	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000368	0.000376	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000367	0.000376	CcSEcCtD
Epirubicin—Nausea—Prednisolone—ankylosing spondylitis	0.000367	0.000376	CcSEcCtD
Epirubicin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000365	0.000374	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—ankylosing spondylitis	0.000365	0.000374	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000365	0.000373	CcSEcCtD
Epirubicin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000363	0.000372	CcSEcCtD
Epirubicin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000361	0.00037	CcSEcCtD
Epirubicin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000361	0.000369	CcSEcCtD
Epirubicin—Rash—Triamcinolone—ankylosing spondylitis	0.000358	0.000367	CcSEcCtD
Epirubicin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000358	0.000367	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—ankylosing spondylitis	0.000358	0.000366	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—ankylosing spondylitis	0.000358	0.000366	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000357	0.000366	CcSEcCtD
Epirubicin—Urticaria—Prednisone—ankylosing spondylitis	0.000357	0.000365	CcSEcCtD
Epirubicin—Headache—Triamcinolone—ankylosing spondylitis	0.000356	0.000365	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—ankylosing spondylitis	0.000355	0.000364	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000355	0.000364	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000355	0.000364	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000353	0.000361	CcSEcCtD
Epirubicin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000353	0.000361	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—ankylosing spondylitis	0.000351	0.000359	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000342	0.00035	CcSEcCtD
Epirubicin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000341	0.000349	CcSEcCtD
Epirubicin—Dizziness—Betamethasone—ankylosing spondylitis	0.000341	0.000349	CcSEcCtD
Epirubicin—Insomnia—Methotrexate—ankylosing spondylitis	0.00034	0.000348	CcSEcCtD
Epirubicin—Nausea—Triamcinolone—ankylosing spondylitis	0.000338	0.000346	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000337	0.000345	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000337	0.000345	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000335	0.000343	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—ankylosing spondylitis	0.000334	0.000342	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000331	0.000339	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00033	0.000338	CcSEcCtD
Epirubicin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000328	0.000336	CcSEcCtD
Epirubicin—Vomiting—Betamethasone—ankylosing spondylitis	0.000328	0.000336	CcSEcCtD
Epirubicin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000326	0.000334	CcSEcCtD
Epirubicin—Rash—Dexamethasone—ankylosing spondylitis	0.000325	0.000333	CcSEcCtD
Epirubicin—Rash—Betamethasone—ankylosing spondylitis	0.000325	0.000333	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000325	0.000333	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000325	0.000333	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000324	0.000332	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—ankylosing spondylitis	0.000324	0.000331	CcSEcCtD
Epirubicin—Headache—Betamethasone—ankylosing spondylitis	0.000323	0.000331	CcSEcCtD
Epirubicin—Headache—Dexamethasone—ankylosing spondylitis	0.000323	0.000331	CcSEcCtD
Epirubicin—Asthenia—Prednisone—ankylosing spondylitis	0.000322	0.00033	CcSEcCtD
Epirubicin—Pain—Methotrexate—ankylosing spondylitis	0.000321	0.000329	CcSEcCtD
Epirubicin—Pruritus—Prednisone—ankylosing spondylitis	0.000318	0.000325	CcSEcCtD
Epirubicin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000309	0.000317	CcSEcCtD
Epirubicin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000307	0.000315	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000307	0.000314	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—ankylosing spondylitis	0.000306	0.000314	CcSEcCtD
Epirubicin—Nausea—Betamethasone—ankylosing spondylitis	0.000306	0.000314	CcSEcCtD
Epirubicin—Urticaria—Methotrexate—ankylosing spondylitis	0.000298	0.000305	CcSEcCtD
Epirubicin—Dizziness—Prednisone—ankylosing spondylitis	0.000297	0.000304	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000297	0.000304	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000297	0.000304	CcSEcCtD
Epirubicin—Vomiting—Prednisone—ankylosing spondylitis	0.000286	0.000292	CcSEcCtD
Epirubicin—Rash—Prednisone—ankylosing spondylitis	0.000283	0.00029	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—ankylosing spondylitis	0.000283	0.00029	CcSEcCtD
Epirubicin—Headache—Prednisone—ankylosing spondylitis	0.000281	0.000288	CcSEcCtD
Epirubicin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000277	0.000283	CcSEcCtD
Epirubicin—Asthenia—Methotrexate—ankylosing spondylitis	0.000269	0.000276	CcSEcCtD
Epirubicin—Nausea—Prednisone—ankylosing spondylitis	0.000267	0.000273	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—ankylosing spondylitis	0.000266	0.000272	CcSEcCtD
Epirubicin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000257	0.000263	CcSEcCtD
Epirubicin—Dizziness—Methotrexate—ankylosing spondylitis	0.000248	0.000254	CcSEcCtD
Epirubicin—Vomiting—Methotrexate—ankylosing spondylitis	0.000239	0.000244	CcSEcCtD
Epirubicin—Rash—Methotrexate—ankylosing spondylitis	0.000237	0.000242	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000236	0.000242	CcSEcCtD
Epirubicin—Headache—Methotrexate—ankylosing spondylitis	0.000235	0.000241	CcSEcCtD
Epirubicin—Nausea—Methotrexate—ankylosing spondylitis	0.000223	0.000228	CcSEcCtD
